C83.98
Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Non-follicular (diffuse) lymphoma, classified under ICD-10 code C83.98, is a type of cancer that originates in the lymphatic system. Unlike follicular lymphomas that develop in follicle structures of the lymph nodes, this form spreads diffusely throughout lymph tissues without forming distinct nodules. It can involve multiple lymph node groups located in different parts of the body, leading to widespread effects. Recognizing and understanding this condition is essential for timely diagnosis and management, although treatment options should always be discussed with healthcare professionals.
Causes & Symptoms
Clinical Causes: Genetic mutations that disrupt normal cell growth regulation Viral infections, such as Epstein-Barr virus (EBV) Exposure to certain chemicals or pesticides Weakened immune system due to prior illnesses or medications Age-related cellular changes, typically affecting older adults
Key Symptoms: Swollen lymph nodes that are painless and typically non-tender Unexplained weight loss Persistent fever without an obvious infection Profuse night sweats Fatigue and general weakness Itching skin Abdominal discomfort or swelling if internal lymph nodes are involved
Diagnostic & Treatment
Diagnosis Path: Diagnosing non-follicular (diffuse) lymphoma involves several steps to confirm the presence and extent of the disease. These include:
Treatment Protocols: Management of non-follicular (diffuse) lymphoma typically involves a combination of therapies aimed at eliminating cancer cells and controlling disease progression. Treatment modalities include:
Clinical Advice & FAQs
Billing Guidance
Is C83.98 a billable ICD-10 code?
Yes, C83.98 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.98?
Clinical documentation must specify the nature of Non-follicular (diffuse) lymphoma, unspecified, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference